条码药物管理系统的使用和安全影响:以临床观察为基础的数据驱动的纵向研究
Rachel Williams1, Kumud Kantilal1, Kenneth K C Man1,2
1Centre for Medicines Optimisation Research and Education-CMORE, University College London Hospitals NHS Foundation Trust, London, UK.
BMJ health & care informatics
|January 20, 2025
概括
条形码药物管理 (BCMA) 系统显示了可变的遵守,随着时间的推移而下降. 质量改善举措是确保持续使用和潜在的患者安全益处的关键.
科学领域:
- 医疗信息学 医疗信息学
- 患者安全 患者安全
- 临床药房 临床药房
背景情况:
- 条形码药物管理 (BCMA) 系统是为了提高患者安全而实施的.
- 成功整合和一致使用对于BCMA的有效性至关重要.
- 了解障碍物和促进因素对于优化BCMA系统性能至关重要.
研究的目的:
- 探索成功使用BCMA系统的障碍和推动因素.
- 检查药物和患者扫描的趋势随着时间的推移.
- 评估与BCMA系统使用相关的潜在安全影响.
主要方法:
- 一项回顾性纵向研究分析了来自五个医院病房的16个月的BCMA数据.
- 数据包括药物和患者扫描率,违规原因以及扫描不匹配警报.
- 回归模型确定了影响不同专业药物扫描率的因素.
主要成果:
- 药物扫描率差异很大 (5.6%67%),患者扫描率也差异很大 (4.6%89%).
- 不扫描的常见原因包括无法阅读的条形码和扫描器不可用;随着时间的推移,率下降.
- 质量改善举措,服药时间和药物配方与更高的扫描率有关;观察到解决方案.
结论:
- 在病房中,BCMA系统的合规性是不一致的,并且随着时间的推移而波动.
- 质量改进举措显示出持续使用BCMA系统的前景.
- 需要进一步的研究来证实BCMA系统的长期安全益处.
相关概念视频
Pharmacovigilance
770
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
770
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
Analysis of Population Pharmacokinetic Data
222
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
222
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
43
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
43


